Results 281 to 290 of about 6,372,774 (389)
Delivering nanomedicine to solid tumors
R. Jain, T. Stylianopoulos
semanticscholar +1 more source
Screening 166 FDA‐approved anticancer drugs identifies the aromatase inhibitor Exemestane as a synergistic partner of PARP inhibitor Olaparib in BRCA‐proficient triple‐negative breast cancer. Exemestane induces ROS‐mediated replication stress, enhancing DNA damage and apoptosis alongside Olaparib.
Nur Aininie Yusoh+5 more
wiley +1 more source
Benign brainstem tumors in children: a retrospective series of 42 patients treated in Lyon. [PDF]
Beuriat PA+5 more
europepmc +1 more source
Pericytes change function depending on glioblastoma vicinity: emphasis on immune regulation
Pericytes alter their transcriptome depending on their proximity to the tumor core. In the tumor core, pericytes display a more active state with higher communication strength but with lower immune activation potential and a shift toward extracellular matrix production.
Carolina Buizza+5 more
wiley +1 more source
Epidemiology of Primary Intracranial Tumors at a Tertiary Care Hospital in Central India: A Retrospective Study. [PDF]
Mishra SS, Ahirwar MK, Nanda S, Rath SM.
europepmc +1 more source
RKIP, a metastasis suppressor protein, modulates key oncogenic pathways in lung adenocarcinoma. In silico analyses linked low RKIP expression to poor survival. Functional studies revealed RKIP overexpression reduces tumor aggressiveness and enhances sensitivity to EGFR‐targeted therapies, while its loss promotes resistance.
Ana Raquel‐Cunha+10 more
wiley +1 more source
Mutations in MLL3 promote breast cancer progression via HIF1α-dependent intratumoral recruitment and differentiation of regulatory T cells. [PDF]
Boutet M+18 more
europepmc +1 more source
REPORT OF TWO CASES OF TUMOR OF THE SPINAL CORD, UNACCOMPANIED WITH SEVERE PAIN [PDF]
Pearce Bailey
openalex +1 more source